Global Chromatography Solvents Market Outlook, 2031

Chromatography solvents are the lifeblood of separation science, flowing through analytical instruments and preparative columns in laboratories and drug plants worldwide. They cover HPLC, UHPLC, LC-MS, GC, thin-layer, flash, preparative and process grades. Acetonitrile is the anchor product, accounting for about 40% of solvent use, followed by methanol at about 20%, high-purity water at 10%, isopropanol and ethanol at around 10%, hexane and heptane at 8%, and tetrahydrofuran, ethyl acetate, acetone and other solvents making up the rest. Analytical HPLC and LC-MS absorb about 60% of demand, preparative and process chromatography around 25%, gas chromatography about 10% and other techniques the remainder. A distinctive feature of this field is that its most important raw material is a by-product: acetonitrile is recovered at roughly 2% to 3% of the output of acrylonitrile plants, so supply is governed by demand for acrylic fibres and ABS plastics, produced by INEOS, Asahi Kasei, Ascend, Formosa and Chinese petrochemical groups, rather than by laboratory needs. Purified grades are supplied by Merck KGaA, Thermo Fisher, Avantor, Honeywell, Biosolve, Carlo Erba, RCI Labscan, Fujifilm Wako, Kanto, Daejung and Chinese producers. Asia-Pacific accounts for about 32% of demand, and North America and Europe about 30% each.

The most powerful new demand driver is industrial-scale purification of peptide and oligonucleotide drugs. Massive investment in GLP-1 manufacturing capacity by Novo Nordisk, Eli Lilly and contract manufacturers from 2023 to 2026 has turned preparative chromatography into a major consumer of high-purity acetonitrile, with columns up to a metre or more in diameter, and this application is expected to grow at around 8% a year, while oligonucleotide drug approvals add further volume. Regulation is reshaping solvent portfolios: the US EPA banned most uses of dichloromethane under TSCA in April 2024, allowing only limited laboratory use under strict controls, and the EU restricted N,N-dimethylformamide from December 2023. Supply risk remains a defining issue, recalling the 2008 to 2009 acetonitrile shortage, when acrylonitrile output fell during the financial crisis and prices multiplied, and the 2026 Iran war and closure of the Strait of Hormuz disrupted Gulf petrochemical exports and raised energy and feedstock costs. Sustainability pressure is moving laboratories toward UHPLC, which can cut solvent use per analysis by 50% to 80%, narrow-bore columns, ethanol-based methods, supercritical fluid chromatography and solvent recycling, moderating analytical volume growth. Asia-Pacific is expected to be the fastest-growing region through 2031 on the back of China's and India's pharmaceutical and peptide manufacturing expansion.

Drivers Growth of Chromatography in Pharmaceuticals and Testing Chromatography is essential in pharmaceutical development, manufacturing quality control, bioanalysis, environmental monitoring, food safety, clinical diagnostics and chemical analysis, and the installed base of HPLC, UHPLC and LC-MS systems continues to grow. Regulations requiring testing for impurities, contaminants such as PFAS and residues drive solvent consumption.
Preparative Chromatography for Peptides and Oligonucleotides Large-scale preparative and process chromatography is used to purify GLP-1 peptides, other peptide drugs, oligonucleotides, insulin and small molecules, consuming large volumes of high-purity acetonitrile and other solvents. Massive investment in GLP-1 manufacturing capacity by Novo Nordisk, Eli Lilly and contract manufacturers and growth of oligonucleotide therapeutics increase demand.

Challenges Acetonitrile Supply Dependence and Price Volatility Acetonitrile is a by-product of acrylonitrile production, so supply depends on demand for acrylonitrile in plastics and fibres, and disruptions can cause shortages and price spikes, as in 2008 to 2009. Petrochemical disruptions and energy price spikes, such as during the 2026 Iran war, affect solvent costs and logistics. Concentration of production in a few countries creates supply risk.
Regulation, Health and Sustainability Pressure Some chromatography solvents are hazardous, and regulations such as the US EPA's 2024 ban on most dichloromethane uses and EU restrictions on DMF require substitution or strict controls. Solvent waste disposal is costly, and laboratories and pharmaceutical companies seek to reduce solvent use, which may limit volume growth in analytical applications.

Trends Solvent Recycling and Green Alternatives Laboratories and manufacturers are recycling acetonitrile and other solvents from preparative chromatography, adopting greener solvents such as ethanol, using supercritical CO₂ in SFC, and reducing consumption with UHPLC, smaller columns and method optimisation. Suppliers offer recycling programmes, bio-based solvents and returnable containers.
Ultra-Pure Grades and Supply Security Demand for LC-MS-grade and PFAS-free solvents is rising with sensitive analyses, and suppliers invest in purification and quality control. Pharmaceutical companies seek multiple qualified suppliers and long-term contracts for acetonitrile and other critical solvents to secure supply.



Acetonitrile accounts for about 40% of chromatography solvent use because it is the preferred reversed-phase organic modifier for analytical HPLC and LC-MS and the main eluent in peptide and oligonucleotide preparative purification. Acetonitrile accounts for about 40% of chromatography solvent use. Its low viscosity allows lower back-pressure at high flow rates, its low UV cutoff enables detection at short wavelengths, and its compatibility with electrospray ionisation makes it the default organic solvent in LC-MS. Preparative purification of GLP-1 and other peptides uses large volumes of acetonitrile-water gradients, and oligonucleotide purification uses acetonitrile with ion-pair reagents, making pharmaceutical manufacturing a major bulk consumer. Methanol accounts for around 20% of use, as a lower-cost alternative with different selectivity, widely used in reversed-phase methods, LC-MS and sample preparation. High-purity water accounts for about 10%, although many laboratories produce their own with purification systems, and bottled LC-MS-grade water is purchased where contamination control is critical. Isopropanol and ethanol account for around 10%, used in normal-phase and chiral separations, column cleaning and increasingly as greener alternatives to acetonitrile. Hexane and heptane account for about 8%, used in normal-phase and chiral chromatography, GC sample preparation and lipid analysis, with heptane often replacing hexane because of hexane's neurotoxicity. Tetrahydrofuran is used in size-exclusion chromatography of polymers, while ethyl acetate, acetone, dichloromethane under strict limits and specialty GC headspace solvents such as dimethyl sulphoxide and dimethylacetamide made up the remainder. Each solvent's pricing reflects its petrochemical feedstock, purification cost and grade, and acetonitrile prices have historically been the most volatile. Deuterated solvents for NMR and specialty solvents for chiral separations form small, high-value niches alongside the main chromatography solvents. Solvent mixtures supplied premixed for specific methods also form a growing convenience category, reducing preparation time.


Analytical chromatography accounts for about 60% of chromatography solvent use because tens of thousands of HPLC, UHPLC and LC-MS systems run continuously in quality control, research and testing laboratories, while preparative and process chromatography is the fastest-growing application. Analytical HPLC, UHPLC and LC-MS applications account for about 60% of solvent demand. A single HPLC system running around the clock can consume several hundred litres of solvent a year, and large pharmaceutical quality control laboratories operate hundreds of systems. UHPLC adoption has reduced solvent use per analysis by 50% to 80% through shorter columns and lower flow rates, but rising analysis volumes have offset much of this saving. Preparative and process chromatography accounts for around 25% of demand, covering laboratory-scale purification in medicinal chemistry, pilot-scale purification for clinical supply and manufacturing-scale columns up to a metre or more in diameter used to purify peptides such as semaglutide and tirzepatide, oligonucleotides, insulin analogues, antibiotics and natural products. This segment is growing at about 8% a year, driven by GLP-1 and oligonucleotide production. Gas chromatography accounts for about 10%, using solvents for sample extraction, dilution and headspace analysis of residual solvents, pesticides and environmental contaminants. Thin-layer chromatography, flash chromatography in synthetic chemistry laboratories and supercritical fluid chromatography, which uses carbon dioxide with small amounts of co-solvent, accounted for the remainder. Solvent recovery and recycling systems are increasingly installed at manufacturing sites to recover acetonitrile from preparative waste streams, reducing both purchasing costs and hazardous waste disposal. Method transfer between analytical and preparative scales influences solvent choice across the value chain. Two-dimensional chromatography and micro-flow LC-MS, used in proteomics and metabolomics, consume smaller volumes but require the highest purity grades. Continuous chromatography systems used in manufacturing can reduce solvent use per gram of product.


HPLC and gradient grades account for large analytical volumes because they meet the specifications of validated UV methods at moderate cost, while LC-MS, UHPLC and bulk process grades are the fastest-growing segments. HPLC and gradient grades account for an estimated 45% of chromatography solvent use, used in validated UV-based methods across pharmaceutical quality control, food testing and academic laboratories. Gradient grades are tested for baseline stability when solvent composition changes during a run. LC-MS grades, with ultra-low metal ions, non-volatile residues and organic contaminants, account for around 20% of use and are growing at an estimated 8% a year as mass spectrometry becomes standard in pharmaceutical bioanalysis, clinical testing and environmental analysis, including PFAS testing that requires certified PFAS-free solvents. UHPLC grades, filtered to remove sub-micron particles, account for about 8%. GC and headspace grades, tested for low levels of volatile impurities, account for around 7%. Bulk process grades supplied in drums, intermediate bulk containers and tank trucks for preparative and process chromatography account for about 15% of use and are the fastest-growing grade by volume, with pharmaceutical manufacturers qualifying suppliers under GMP and requiring consistent specifications. Pharmacopoeia-compliant grades are specified in regulated testing. Pricing varies widely, with LC-MS grades commanding substantial premiums over bulk grades. Packaging innovations, including nitrogen-blanketed containers, returnable stainless steel drums and closed transfer systems, reduce contamination and exposure. Suppliers increasingly differentiate through lot consistency, impurity profiles relevant to specific detectors and certificates documenting absence of interfering compounds. Regional purification plants near pharmaceutical clusters help reduce logistics costs and supply risk. Grade selection is increasingly guided by detector type and sensitivity requirements rather than tradition. Bulk users often audit solvent production sites as part of GMP supplier qualification, adding to switching costs.

Pharmaceutical and biotechnology companies account for the largest share of chromatography solvent demand because they combine heavy analytical testing with large-scale preparative purification, while testing laboratories, academia and chemical companies form other major user groups. Pharmaceutical and biotechnology companies, including contract development and manufacturing organisations and peptide and oligonucleotide manufacturers, account for an estimated 55% of chromatography solvent demand. They use solvents throughout research, development, quality control and manufacturing, and peptide producers such as Novo Nordisk, Eli Lilly, Bachem, PolyPeptide and Chinese and Indian CDMOs are among the largest bulk acetonitrile buyers. Testing laboratories, including environmental, food, contract analytical and forensic laboratories, account for around 15%, running high volumes of routine analyses for regulatory compliance. Academic and government research laboratories account for about 12%, using a wide variety of solvents in small volumes across disciplines. Clinical laboratories account for around 6%, using LC-MS solvents for therapeutic drug monitoring, toxicology and endocrinology tests. Chemical, petrochemical, polymer and cosmetics companies account for about 8%, using chromatography for product quality and research, including size-exclusion chromatography for polymers. Cannabis and natural product testing and purification formed a smaller segment, notable in North America. Purchasing behaviour differs sharply between analytical users, who buy many small bottles through distributors, and process users, who negotiate long-term bulk contracts directly with producers. Large users increasingly evaluate total cost, including waste disposal and recycling credits, rather than purchase price alone. Environmental, health and safety requirements influence solvent selection, with users replacing hexane, dichloromethane and DMF where possible. Green chemistry scorecards used by pharmaceutical companies guide solvent choices in new methods. Academic and research users are also increasingly influenced by institutional sustainability programmes that encourage solvent sharing, recycling and greener method development. Hospital laboratories and public health agencies form a smaller but stable source of demand.


Asia-Pacific accounts for about 32% of chromatography solvent demand and is the fastest-growing region, while North America and Europe each account for about 30%. Asia-Pacific accounts for about 32% of global demand and is the fastest-growing region, led by China, a major producer and exporter of acetonitrile and other solvents and a large consumer through its pharmaceutical, CRO and peptide manufacturing industries, India, with large generic pharmaceutical and peptide manufacturing sectors, and Japan and South Korea, with advanced pharmaceutical and testing industries. North America accounts for about 30%, with large pharmaceutical, biotechnology, GLP-1 manufacturing and testing industries, and the EPA's 2024 dichloromethane restrictions shaping solvent use. Europe accounts for about 30%, with major pharmaceutical producers, including Novo Nordisk's large GLP-1 facilities in Denmark, strict chemical regulation under REACH, including DMF restrictions, and suppliers such as Merck KGaA, Biosolve and Carlo Erba. The Middle East, Latin America and Africa have smaller markets, though Gulf petrochemical disruptions in 2026 affected global solvent supply chains.


• March 2026 – Hormuz crisis disrupts petrochemical supply chains: The closure of the Strait of Hormuz disrupted Gulf petrochemical exports and raised energy and feedstock costs, affecting prices and logistics for some solvents.
• 2025 – GLP-1 manufacturing expansion increases preparative solvent demand: Large investments in GLP-1 peptide production capacity by Novo Nordisk, Eli Lilly and contract manufacturers increased demand for acetonitrile and other preparative chromatography solvents.
• July 2025 – Waters agrees to combine with BD's Biosciences and Diagnostic Solutions: Waters' transaction with BD's biosciences business expanded its life science tools portfolio, which includes chromatography instruments and consumables.
• April 2024 – US EPA bans most uses of dichloromethane: The EPA finalised a TSCA rule banning most uses of methylene chloride, with limited laboratory uses allowed under strict workplace controls, encouraging substitution in chromatography.
• December 2023 – EU restriction on DMF takes effect: The EU restricted use of N,N-dimethylformamide above set concentrations unless exposure limits are met, encouraging alternatives in laboratories and manufacturing.

Considered in this report
• Historic Year: 2020
• Base Year: 2025
• Estimated Year: 2026
• Forecast Year: 2031

Aspects covered in this report
• Global Chromatography Solvents Market with its value and forecast along with its segments
• Various drivers and challenges
• Ongoing trends and developments
• Top profiled companies
• Strategic recommendation

By Solvent Type
• Acetonitrile
• Methanol
• Water
• Isopropanol and Ethanol
• Hexane and Heptane
• Tetrahydrofuran
• Other Solvents

By Application
• Analytical HPLC and LC-MS
• Preparative and Process Chromatography
• Gas Chromatography
• Thin-Layer and Flash Chromatography
• Supercritical Fluid Chromatography

By Grade
• HPLC and Gradient Grade
• LC-MS Grade
• UHPLC Grade
• GC Grade
• Bulk Process Grade

By End User
• Pharmaceutical and Biotechnology Companies
• CDMOs and Peptide Manufacturers
• Testing Laboratories
• Academic and Government Research
• Clinical Laboratories
• Chemical Companies